Dr. Marty Makary, the FDA’s commissioner, said the program targets “dead time,” or about half the time between the launch of ...
CorFlow Therapeutics AG (CorFlow), a clinical-stage company focused on transforming the diagnosis and treatment for heart attack patients, today announced multiple milestones in advancing its clinical ...
By Ahmed Aboulenein WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday ...
Bringing medical school–level training to high school students through immersive technology and hands-on learning We ...
Updates to outpatient program coordination for adults and teenagers seeking mental health treatment Atlanta services have ...
Voucher application details focus on AUD as a major driver of the U.S. substance use crisis and the genetic targeting of AD04 ...
The US Food and Drug Administration (FDA) has announced plans for a future pilot program intended to facilitate the real-time ...
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with ...
FDA-regulator access to near real-time safety and endpoint streams is intended to enable earlier signal detection and more ...
Two sponsors are on board, with a larger pilot program planned later this year ...
The first-of-its-kind pilot could lead to speedier regulatory approval of medical drugs and devices and potentially reduce ...
The U.S. Food and Drug Administration today announced two major steps as part of an initiative to advance the implementation of real-time clinical trials (RTCT). First, the agency unveiled the ...